In T2DM, studies have shown that NRF2-regulated genes such as NQO1, HMOX1, GCLC, and TXNRD1 serve as important biomarkers for therapeutic response, oxidative stress modulation, and disease progression. The gene discussed is GCLC; the disease is type 2 diabetes mellitus.